Sorafenib and Bevacizumab in Combination With Paclitaxel in Patients With Solid Tumors

NCT00572078 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

SOLID TUMORS

Interventions

DRUG: Sorafenib

Sponsor

Safi Shahda

Collaborators

[object Object]
[object Object]